It is one of the few weight measures that has passed the ramp in Parliament to curb the costs of health: the discounts imposed on pharmaceutical companies on highly prescribed drugs. But as a result of Donald Trump's pressure, these rebates are now being called into question.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
It is one of the few weight measures that has passed the ramp in Parliament to curb the costs of health: the discounts imposed on pharmaceutical companies on highly prescribed drugs. But as a result of Donald Trump's pressure, these rebates are now being called into question.